Brain Scientific Stock Today
| BRSF Stock | USD 0.75 0.00 0.00% |
Performance0 of 100
| Odds Of DistressLess than 22
|
Brain Scientific is trading at 0.75 as of the 26th of November 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 0.75. Brain Scientific has about a 22 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for Brain Scientific are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 7th of December 2022 and ending today, the 26th of November 2024. Click here to learn more.
Brain Scientific Inc., a medtech company, provides neurology-focused medical devices and electric motors in the United States. Brain Scientific Inc. was founded in 2013 and is headquartered in Sarasota, Florida. Brain Scientific operates under Medical Devices classification in the United States and is traded on OTC Exchange. The company has 105.4 M outstanding shares. More on Brain Scientific
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Brain Pink Sheet Highlights
| Business Concentration | Medical Devices, Healthcare (View all Sectors) |
Brain Scientific [BRSF] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Small-Cap' category with a current market capitalization of 316.21 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Brain Scientific's market, we take the total number of its shares issued and multiply it by Brain Scientific's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Brain Scientific conducts business under Healthcare sector and is part of Medical Devices industry. The entity has 105.4 M outstanding shares.
Brain Scientific currently holds about 3.54 M in cash with (5.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03.
Check Brain Scientific Probability Of Bankruptcy
Ownership AllocationBrain Scientific holds a total of 105.4 Million outstanding shares. Brain Scientific retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Brain Ownership Details
Brain Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Brain Scientific without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run CEOs Directory Now
CEOs DirectoryScreen CEOs from public companies around the world |
| All Next | Launch Module |
Brain Scientific Corporate Management
| Hassan Kotob | CEO Chairman | Profile | |
| Irina Nazarova | Director Marketing | Profile | |
| Farid Anthony | Chief Officer | Profile | |
| Daniel Cloutier | Chief Director | Profile | |
| Kevin Winterfield | VP Communications | Profile | |
| BonnieJeanne Gerety | Chief Officer | Profile | |
| Vadim Sakharov | Consultant | Profile |
Other Information on Investing in Brain Pink Sheet
Brain Scientific financial ratios help investors to determine whether Brain Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Brain with respect to the benefits of owning Brain Scientific security.